Exscientia Plc (Exscientia) is an artificial intelligence-driven pharma tech company committed to discovering, designing, and developing drugs. The Company’s AI process is comprised of five elements, including Precision Target, Precision Design, Precision Experiment, Precision Medicine and Presentations and Publications.

Its Precision Target combines genetic data and global literature in machine learning models to anticipate and confirm disease-target associations. Exscientia’s advanced biophysical and x-ray techniques provide the experimental underpinnings for AI-design.

The company gets high-precision information from viable patient tissue, screened in our own laboratories, with their carefully engineered CentaurAI systems, empowers target selection, precision design & experiment, as well as enhanced clinical assessment

Exscientia is headquartered in Oxford, the UK.